Mr. Abraham has more than 30 years of experience in the medical device industry, including executive leadership roles at Stryker, Amedica and Isotis Orthobiologics.
Most recently, he served as managing director of NuVasive’s Australia and New Zealand subsidiary, where he was responsible for the sales, marketing, operations and finance departments.
Prior to joining NuVasive, Mr. Abraham was senior vice president of global sales at Amedica and senior director of orthopedic trauma sales at Stryker.
More articles on devices:
AAOS, OREF partner to drive funding for biologic, total joint replacement research
NuVasive Q1 net income drops 43.6%, shares down 27% since start of year
Dr. Charles Branch Jr.: Imaging, patient engagement big opportunities in spine post-pandemic
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
